Table of contents
30 September 2011
30 September 2011
Daniela C. Kroy, Georg M. Lauer – 28 September 2011
Massimo Pinzani – 28 September 2011
Erin M. McCartney, Nicholas S. Eyre, Michael R. Beard – 28 September 2011
Francisco Javier Cubero, Gang Zhao, Christian Trautwein – 28 September 2011
Takeji Umemura, Satoru Joshita, Tetsuya Ichijo, Kaname Yoshizawa, Yoshihiko Katsuyama, Eiji Tanaka, Masao Ota, The Shinshu PBC Study Group – 27 September 2011 – Along with twin and family studies, recent genome‐wide association studies suggest that genetic factors contribute to the susceptibility and severity of primary biliary cirrhosis (PBC).
Ming Hu, Fengming Wang, Xin Li, Christopher Q. Rogers, Xiaomei Liang, Brian N. Finck, Mayurranjan S. Mitra, Ray Zhang, Dave A. Mitchell, Min You – 27 September 2011 – Lipin‐1 is a protein that exhibits dual functions as a phosphatidic acid phosphohydrolase enzyme in the triglyceride synthesis pathways and a transcriptional coregulator. Our previous studies have shown that ethanol causes fatty liver by activation of sterol regulatory element‐binding protein 1 (SREBP‐1) and inhibition of hepatic AMP‐activated protein kinase (AMPK) in mice.
Nataliya Razumilava, Steve F. Bronk, Rory L. Smoot, Christian D. Fingas, Nathan W. Werneburg, Lewis R. Roberts, Justin L. Mott – 27 September 2011 – It has been established that microRNA expression and function contribute to phenotypic features of malignant cells, including resistance to apoptosis. Although targets and functional roles for a number of microRNAs have been described in cholangiocarcinoma, many additional microRNAs dysregulated in this tumor have not been assigned functional roles.
Raquel Urtasun, Aritz Lopategi, Joseph George, Tung‐Ming Leung, Yongke Lu, Xiaodong Wang, Xiaodong Ge, Maria Isabel Fiel, Natalia Nieto – 27 September 2011 – A key feature in the pathogenesis of liver fibrosis is fibrillar Collagen‐I deposition; yet, mediators that could be key therapeutic targets remain elusive. We hypothesized that osteopontin (OPN), an extracellular matrix (ECM) cytokine expressed in hepatic stellate cells (HSCs), could drive fibrogenesis by modulating the HSC pro‐fibrogenic phenotype and Collagen‐I expression.
Sufen Shang, Amelie Plymoth, Shaokui Ge, Ziding Feng, Hugo R. Rosen, Suleeporn Sangrajrang, Pierre Hainaut, Jorge A. Marrero, Laura Beretta – 27 September 2011 – The aim of this study was to identify a biomarker that could improve alpha‐fetoprotein (AFP) performance in hepatocellular carcinoma (HCC) surveillance among patients with cirrhosis. We performed proteomic profiling of plasma from patients with cirrhosis or HCC and validated selected candidate HCC biomarkers in two geographically distinct cohorts to include HCC of different etiologies.